Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company that manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in the targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of its AID systems, it offers pump integration with multiple CGM sensors.
BörsenkürzelTNDM
Name des UnternehmensTandem Diabetes Care Inc
IPO-datumNov 13, 2013
Gegründet am2008
CEOMr. John F. Sheridan
Anzahl der mitarbeiter2650
WertpapierartOrdinary Share
GeschäftsjahresendeNov 13
Addresse12400 High Bluff Drive
StadtSAN DIEGO
BörseNASDAQ Global Market Consolidated
LandUnited States of America
Postleitzahl92130
Telefon18583666900
Websitehttps://www.tandemdiabetes.com/
BörsenkürzelTNDM
IPO-datumNov 13, 2013
Gegründet am2008
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten